Latest

dementia

The image shows the amyloid fibril proteins discussed in the article.

·May 20, 2013·4 min read

Molecular Trigger for Alzheimer’s Disease Identified

A new study has pinpointed a catalytic trigger for the onset of Alzheimer's disease. The findings could play a central role in the diagnostics and new drug development for neurodegenerative diseases.

Featured Genetics Open Neuroscience Articles

·May 8, 2013·5 min read

New Study Identifies Two Genes That Combine to Cause Rare Syndrome

Researchers find genetic mutations which appear to underlie a rare syndrome which combines reproductive failure with cerebella ataxi and dementia.

Featured Neurology

·March 28, 2013·5 min read

New Research on the Effects of Traumatic Brain Injury

According to three new studies, numerous opportunities exist to improve the outcomes of TBI in older adults.

The image shows a doctor reviewing a patient's electronic medical records.

Featured Neuroscience

·March 14, 2013·3 min read

Dynamic New Software Improves Care of Aging Brain

Researchers develop new medical records software which helps monitor the health of the aging brain.

The image is a diagram comparing the difference between neuron damage and associated damage in alzheimer's disease with normal neurons.

Featured Neurology

·March 8, 2013·2 min read

Buphenyl Identified as a Possible Drug for Alzheimer’s Disease

Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer's disease, a new study finds.

The image shows the chemical structure of neuroserpin.

Featured Neurology

·March 5, 2013·2 min read

Age Related Dementia May Begin with Neurons’ Inability to Rid Themselves of Unwanted Proteins

Researcher discover age related dementia likely occurs due to the declining ability for neurons to dispose of unwanted aggregated proteins.

The image shows a coronal view of a brain scan of a person with ALS.

Featured Neurology

·March 1, 2013·3 min read

Misplaced Molecules: New Insights into the Causes of Dementia

New research supports the idea that a malfunction of the TDP-43 protein plays a decisive role in the development of ALS and FTD.

The image shows 3 diagrams of beta amyloid plaque formations.

Featured Neurology

·February 27, 2013·2 min read

Researchers Identify Possible Treatment Window for Memory Problems

A new study identifies a potential treatment window of several years for plaques in the brain considered to cause memory loss in diseases such as Alzheimer's.

The image shows defective protein cells. The caption best describes the image.

Featured Genetics

·February 26, 2013·5 min read

Researchers Find Controlling Element of Huntington’s Disease

Researchers discover a three molecule complex could be a target for treating Huntington's Disease, a genetic and currently incurable brain disease which causes movement disorders and dementia.

The image shows a comparative brain PET scan of a person with alzheimer's and one without the disease.

Featured Genetics

·February 20, 2013·6 min read

Genome-Wide Imaging Study Identifies New Gene Associated with Alzheimer’s Plaques

Researchers combined genetic data with neuroimaging in order to identify genes associated with amyloid plaque deposits in Alzheimer's disease patients. The study is believed to be the first genome-wide association study of plaque deposits using a specialized PET scan tracer that binds to amyloid.

The image shows brain scans of Alzheimer's patients.

Featured Neurology

·February 19, 2013·2 min read

It’s Not Just Amyloid: White Matter Hyperintensities and Alzheimer’s Disease

A new study suggest that along with amyloid deposits, white matter hyperintensities may be a second necessary factor for the development of Alzheimer’s disease.

The image shows a chart of the activation and antagonists of NMDA receptors.

Electrophysiology Featured Neuroscience

·February 19, 2013·2 min read

Rewriting a Receptor’s Role

Researchers upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons. The study describes how a compound linked to Alzheimer's disease impacts NMDA receptors and weakens synaptic connections between brain cells.